Skip to main content

CORRECTION article

Front. Endocrinol., 22 February 2018
Sec. Clinical Diabetes
Volume 9 - 2018 | https://doi.org/10.3389/fendo.2018.00050

Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

This article is a correction to:

  1. Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

    1. Read original article
\r\nThomas Nystrm*Thomas Nyström1*Irene Santos-PardoIrene Santos-Pardo1Fredric HedbergFredric Hedberg1Johan WardellJohan Wardell1Nils WittNils Witt1Yang Cao,Yang Cao2,3Leif BojLeif Bojö4Bo NilssonBo Nilsson4Johan Jendle\r\nJohan Jendle5
  • 1Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden
  • 2Institution of Medical Sciences, Örebro University, Örebro, Sweden
  • 3Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
  • 4Central Hospital, Karlstad, Sweden
  • 5Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden

A corrigendum on

Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
by Nyström T, Santos-Pardo I, Hedberg F, Wardell J, Witt N, Cao Y, et al. Front Endocrinol (2017) 8:325. doi: 10.3389/fendo.2017.00325

One of the authors name, Irene Santos-Pardo, was misspelled in the published manuscript (as Irene Padro Santos). The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way.

The original article was updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: longitudinal functional reserve index, liraglutide, subclinical heart failure, tissue Doppler echocardiography, type 2 diabetes

Citation: Nyström T, Santos-Pardo I, Hedberg F, Wardell J, Witt N, Cao Y, Bojö L, Nilsson B and Jendle J (2018) Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study. Front. Endocrinol. 9:50. doi: 10.3389/fendo.2018.00050

Received: 31 January 2018; Accepted: 05 February 2018;
Published: 22 February 2018

Edited and Reviewed by: Frontiers in Endocrinology Editorial Office, Frontiers, Switzerland

Copyright: © 2018 Nyström, Santos-Pardo, Hedberg, Wardell, Witt, Cao, Bojö, Nilsson and Jendle. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Thomas Nyström, thomas.nystrom@sll.se

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.